|
|
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
100 Clinical Results associated with TLR9 x CD20 x CD23
100 Translational Medicine associated with TLR9 x CD20 x CD23
0 Patents (Medical) associated with TLR9 x CD20 x CD23